RLAY Stock Summary and Trading Ideas (Relay Therapeutics | NASDAQ:RLAY)

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Relay Therapeutics trades on the NASDAQ stock market under the symbol RLAY.

As of March 3, 2025, RLAY stock price declined to $3.20 with 2,988,120 million shares trading.

RLAY has a beta of 2.35, meaning it tends to be more sensitive to market movements. RLAY has a correlation of 0.18 to the broad based SPY ETF.

RLAY has a market cap of $542.47 million. This is considered a Small Cap stock.

Last quarter Relay Therapeutics reported $0 in Revenue and -$.45 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.10.

In the last 3 years, RLAY traded as high as $35.36 and as low as $3.02.

The top ETF exchange traded funds that RLAY belongs to (by Net Assets): VTI, VB, IWM, VBK, XBI.

RLAY has underperformed the market in the last year with a price return of -68.3% while the SPY ETF gained +16.7%. RLAY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.3% and -20.0%, respectively, while the SPY returned -2.2% and -4.3%, respectively.

RLAY support price is $3.23 and resistance is $3.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RLAY shares will trade within this expected range on the day.